Immunoglobulin G is the main protective antibody in mouse vaginal secretions after vaginal immunization with attenuated herpes simplex virus type 2
about
A caprine herpesvirus 1 vaccine adjuvanted with MF59™ protects against vaginal infection and interferes with the establishment of latency in goatsFunctional characterization of antibodies against Neisseria gonorrhoeae opacity protein loopsSpecific-antibody-secreting cells in the rectums and genital tracts of nonhuman primates following vaccination.Mucosal immunity to herpes simplex virus type 2 infection in the mouse vagina is impaired by in vivo depletion of T lymphocytes.Immunoglobulin G, plasma cells, and lymphocytes in the murine vagina after vaginal or parenteral immunization with attenuated herpes simplex virus type 2Role of the individual interferon systems and specific immunity in mice in controlling systemic dissemination of attenuated pseudorabies virus infection.Modulation of immunity against herpes simplex virus infection via mucosal genetic transfer of plasmid DNA encoding chemokines.Immunobiology of herpes simplex virus and cytomegalovirus infections of the fetus and newbornVaccine-induced serum immunoglobin contributes to protection from herpes simplex virus type 2 genital infection in the presence of immune T cells.Interleukin-12 (IL-12) and IL-18 are important in innate defense against genital herpes simplex virus type 2 infection in mice but are not required for the development of acquired gamma interferon-mediated protective immunity.Genital antibody responses in mice after intranasal infection with an attenuated candidate vector strain of Bordetella pertussis.Anti-glycoprotein g antibodies of herpes simplex virus 2 contribute to complete protection after vaccination in mice and induce antibody-dependent cellular cytotoxicity and complement-mediated cytolysisCervico-vaginal immunoglobulin G levels increase post-ovulation independently of neutrophils.Transfer of IgG in the female genital tract by MHC class I-related neonatal Fc receptor (FcRn) confers protective immunity to vaginal infection.Cervicovaginal neutralizing antibodies to herpes simplex virus (HSV) in women seropositive for HSV Types 1 and 2.Local delivery of CpG oligodeoxynucleotides induces rapid changes in the genital mucosa and inhibits replication, but not entry, of herpes simplex virus type 2.A neonatal Fc receptor-targeted mucosal vaccine strategy effectively induces HIV-1 antigen-specific immunity to genital infection.Efficient mucosal vaccination mediated by the neonatal Fc receptor.Quantitative analysis of herpes simplex virus type 1-specific memory B cells generated by different routes of infection.Herpes simplex virus-2 glycoprotein interaction with HVEM influences virus-specific recall cellular responses at the mucosa.Recombinant Listeria monocytogenes expressing an immunodominant peptide fails to protect after intravaginal challenge with herpes simplex virus-2Induction of mucosal immunity through systemic immunization: Phantom or reality?Immunity to vaginal herpes simplex virus-2 infection in B-cell knockout mice.Immune responses and protection against vaginal infection after nasal or vaginal immunization with attenuated herpes simplex virus type-2.Cellular and Humoral Immunity Protect against Vaginal Zika Virus Infection in Mice.Vaccine-induced antibodies to herpes simplex virus glycoprotein D epitopes involved in virus entry and cell-to-cell spread correlate with protection against genital disease in guinea pigs.
P2860
Q28730610-E8EC722E-FDF7-4A16-BDDB-63DAED38F35FQ30942705-4298B260-3CDC-44A9-AB1A-105AD3F1954AQ33769451-1EA4DDFE-798E-42AA-8D81-B4D2F45842F6Q33782992-1AAD122E-7E75-4034-B989-2F03ECD8B62EQ33784607-73C3FD17-D8D7-489A-9BC2-214290806BB1Q33813762-FF6848B4-9BA5-4CD0-B626-C2F52BA9F2BEQ33835204-C24F8284-BFA7-4DCC-BAB4-9FD56EA50C6BQ33835386-FC8354E0-4E1D-4DFA-A313-4E9339BE9175Q33836053-A9375F7C-F3AF-43AB-8D94-07BBF999EA6FQ33843902-909D5329-0B81-4214-8619-0542870CBD5BQ34003167-4ACA8EB3-D1FF-44F7-AF51-CB3D41DFC6CEQ34580831-D1D70AC6-B2D0-4A65-AA0B-451A239C2C02Q34640774-E5FCB8D0-61A7-4FC8-9B82-99D50336F56EQ34693822-8220C501-7311-4F09-A6E8-C3864B31D399Q34995949-226C6582-5D2D-4682-ABAD-9C5AA6D67923Q35182216-A98B6C31-FDD9-4020-8A13-606FC3457C84Q35274924-0DB29770-ACBC-4ADC-86B0-DF1C3CE9B82DQ35399345-42C7A499-4493-415E-A26B-00C8F471C149Q35758163-16DD51A9-BDFA-4DF7-8E09-FBDD3FC15214Q35986776-52903526-2225-4FAF-8BF3-B6B52ED7C40CQ37082143-558619A9-B971-4832-99E3-9C90426D0947Q37130744-E0509547-5277-4D73-92C5-A6235936350BQ45740405-9A230334-1AAB-4C6F-B2B3-291D930B4231Q45745771-90F70AE2-382A-46CF-9EE3-E02DAB32A2E4Q47552139-3F9389E2-FA43-4C5B-B786-D59D4D08FAF1Q55406946-A080B90B-249C-41FB-A5EB-E3A244187DE8
P2860
Immunoglobulin G is the main protective antibody in mouse vaginal secretions after vaginal immunization with attenuated herpes simplex virus type 2
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Immunoglobulin G is the main p ...... ed herpes simplex virus type 2
@ast
Immunoglobulin G is the main p ...... ed herpes simplex virus type 2
@en
type
label
Immunoglobulin G is the main p ...... ed herpes simplex virus type 2
@ast
Immunoglobulin G is the main p ...... ed herpes simplex virus type 2
@en
prefLabel
Immunoglobulin G is the main p ...... ed herpes simplex virus type 2
@ast
Immunoglobulin G is the main p ...... ed herpes simplex virus type 2
@en
P2860
P1433
P1476
Immunoglobulin G is the main p ...... ed herpes simplex virus type 2
@en
P2093
P2860
P304
P407
P577
1997-11-01T00:00:00Z